Home › Neutropenia
Neutropenia clinical trials recruiting in the U.S.
6 studies for Neutropenia are recruiting participants at sites across the United States.
Recently updated studies
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT06056297Study of Trilaciclib and Lurbinectidin
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05578326Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT05537896Shwachman Diamond Syndrome Registry and Study
RecruitingObservational study
All ages · All sexes · Updated Apr 6, 2026 · NCT06056908Luspatercept for Clonal Cytopenias of Uncertain Significance
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT06788691Serial Blood Count Study
RecruitingEarly phase 1
Ages 5 and older · All sexes · Updated Jul 15, 2025 · NCT07066085From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.